SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DPII: Discovery Partners Int'l
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (67)4/25/2006 4:27:31 PM
From: Mike McFarland  Read Replies (1) of 111
 
As far as I can tell, the only play here is the
bet that Infinity succeeds--which would
obviously overwhelm whatever DPII/INFI do
in the short term as far as the reverse ipo.

I have to say, I don't think Infinity is one
that is going to get tons of positive spin
for awhile, right? In a normal IPO there is
a lot of hype --there is no incentive to hype
this deal.

And as far as I can tell, there is plenty of
competition in the hsp90 area.

The presentation posted on edgar doesn't do
anything for me--I've seen these things before,
it reminds me of the ones I used to see done up
by Targeted Genetics...and those shares never did
much for me.

All I can do is fall back on the fact that
it is just as easy to make money in stocks by not
knowing anything as it is to lose money by knowing
stuff, ha!

In the meantime, check this scientist out:
mskcc.org

It appears she has written on the Vernalis hsp90 inhibitor,
as well as the Infinity drug. But I could not find a
freebie paper.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News